A61K 51/1009
Against material from bacteria
Official title: {against material from bacteria}
A61K51/1009 (Against material from bacteria) appears on 17 US grants and 18 published applications in this corpus.
Search patents in A61K- Granted patents
- 17
- Published applications
- 18
- Assignees
- 24
- Inventors
- 39
- Latest grant
- 18 Jul 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 2 | 0 |
| 2012 | 1 | 3 |
| 2013 | 2 | 2 |
| 2014 | 1 | 1 |
| 2015 | 1 | 2 |
| 2016 | 0 | 1 |
| 2017 | 2 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Synthetic anti-plague antibodies18 Jul 2023US 11,702,465 B1Triad National Security, LLC
- Anti-C3d antibody conjugates and methods of detecting complement activation7 Dec 2021US 11,191,851 B2MUSC Foundation for Research Development
- Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging17 Sep 2019US 10,413,620 B2The Johns Hopkins University
- Monoclonal antibodies that neutralize anthrax toxins21 Aug 2018US 10,053,503 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Method for targeting antigens unique to a tumor31 Oct 2017US 9,801,937 B1Dartmouth-Hitchcock Clinic
- Anti-C3d antibody conjugates and methods of detecting complement activation1 Oct 2020US 2020/0308295 A1Dept. of Veterans Affairs
- Light-Emitting Versions of the Monoclonal Antibody to C3D (MAB 3D29) for Imaging8 Aug 2019US 2019/0240355 A9The Johns Hopkins University
- Monoclonal Antibodies that Neutralize Anthrax Toxins26 Apr 2018US 2018/0111981 A1The USA, as represented by the Secretary, Dept. of Health and Human Services
- Light-Emitting Versions of the Monoclonal Antibody to C3D (MAB 3D29) for Imaging12 Oct 2017US 2017/0290930 A1The John Hopkins University
- Monoclonal antibodies that neutralize anthrax toxins14 Jul 2016US 2016/0200803 A1The United States of America, as represented by the Secretary, Department of Health and Human Services
Most cited
By later US patents
- Human monoclonal antibodies against Bacillus anthracis protective antigen74US 7,456,264 B2Medarex, Inc. · 2008
- Antibody recognizing endothelial cell ligand for leukocyte CR39US 5,792,457 AThe Rockefeller University · 1998
- Peptides which inhibit adhesion between leukocytes and endothelial cells8US 5,932,217 AThe Rockefeller University · 1999
- Human monoclonal antibodies against Hendra and Nipah viruses7US 7,988,971 B2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. · 2011
- Human monoclonal antibodies against hendra and nipah viruses7US 8,313,746 B2The Henry Jackson Foundation for the Advancement of Military Medicine · 2012